These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30883650)

  • 21. [Influence of phosphoglycerate kinase 1 on metastasis and invasion of hepatoma cells and prognosis of liver cancer].
    Zhang L; Wang YC; Xie XY; Chen J; Gao DM; Ren ZG
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):446-451. PubMed ID: 28763863
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
    J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma.
    Tsang CM; Cheung KC; Cheung YC; Man K; Lui VW; Tsao SW; Feng Y
    Biochim Biophys Acta; 2015 Mar; 1852(3):541-51. PubMed ID: 25496992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion.
    Ao J; Meng J; Zhu L; Nie H; Yang C; Li J; Gu J; Lin Q; Long W; Dong X; Li C
    Mol Oncol; 2012 Oct; 6(5):507-15. PubMed ID: 22819717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
    Pei T; Meng Q; Han J; Sun H; Li L; Song R; Sun B; Pan S; Liang D; Liu L
    Oncotarget; 2016 Jul; 7(28):43475-43491. PubMed ID: 27259268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway.
    Ma W; Wong CC; Tung EK; Wong CM; Ng IO
    Hepatology; 2013 Jan; 57(1):152-61. PubMed ID: 22829315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma.
    Hu F; Deng X; Yang X; Jin H; Gu D; Lv X; Wang C; Zhang Y; Huo X; Shen Q; Luo Q; Zhao F; Ge T; Zhao F; Chu W; Shu H; Yao M; Fan J; Qin W
    Oncogene; 2015 Dec; 34(49):6007-17. PubMed ID: 25745995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma.
    Wang C; Jin G; Jin H; Wang N; Luo Q; Zhang Y; Gao D; Jiang K; Gu D; Shen Q; Huo X; Hu F; Ge T; Zhao F; Chu W; Shu H; Yao M; Cong W; Qin W
    Oncotarget; 2015 Feb; 6(5):2903-16. PubMed ID: 25609201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
    Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
    Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT3 activation mediates epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang CH; Guo FL; Xu GL; Jia WD; Ge YS
    Hepatogastroenterology; 2014 Jun; 61(132):1082-9. PubMed ID: 26158169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raf kinase inhibitor protein mediated signaling inhibits invasion and metastasis of hepatocellular carcinoma.
    Wu X; Yang Y; Xu Z; Li J; Yang B; Feng N; Zhang Y; Wang S
    Biochim Biophys Acta; 2016 Feb; 1860(2):384-91. PubMed ID: 26116914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3/Girdin/Akt activity.
    Ke Y; Bao T; Wu X; Tang H; Wang Y; Ge J; Fu B; Meng X; Chen L; Zhang C; Tan Y; Chen H; Guo Z; Ni F; Lei X; Shi Z; Wei D; Wang L
    Biochem Biophys Res Commun; 2017 Jan; 483(1):509-515. PubMed ID: 27998773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion.
    Wong CC; Wong CM; Tung EK; Man K; Ng IO
    Hepatology; 2009 May; 49(5):1583-94. PubMed ID: 19205033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.
    Zhou Z; Jiang H; Tu K; Yu W; Zhang J; Hu Z; Zhang H; Hao D; Huang P; Wang J; Wang A; Xiao Z; He C
    J Exp Clin Cancer Res; 2019 Jan; 38(1):18. PubMed ID: 30646949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients.
    Ruan J; Zheng H; Rong X; Rong X; Zhang J; Fang W; Zhao P; Luo R
    Mol Cancer; 2016 Feb; 15():17. PubMed ID: 26896959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
    Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
    Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance.
    Zhang CH; Xu GL; Jia WD; Li JS; Ma JL; Ren WH; Ge YS; Yu JH; Liu WB; Wang W
    J Surg Res; 2012 May; 174(1):120-9. PubMed ID: 21316706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.